Waldenstroms macroglobulinemia or immunoglobulin (Ig)M myeloma
Waldenstrm's macroglobulinemia
Clinicopathological diagnosis of Waldenstroms macroglobulinemia and meeting criteria for treatment using consensus panel criteria from the Second International Workshop on Waldenstroms macroglobulinemia (Kyle et al, ) or have high risk disease with an serum IgM level of , mg or higher (Gustine et al, )
PART I: Patients with Waldenstroms macroglobulinemia (WM) must meet the indications for treatment per the International Workshop on Waldenstroms Macroglobulinemia (IWWM)
PART IB: Patients with Waldenstroms macroglobulinemia (WM) must meet the indications for treatment per the International Workshop on Waldenstroms Macroglobulinemia (IWWM)
Lymphoplasmacytoid lymphoma/Waldenstrm macroglobulinemia (LPL/WM)
Lymphoplasmacytoid lymphoma/Waldenstrm macroglobulinemia (LPL/WM)
Criteria  Waldenstrm macroglobulinemia
Waldenstrm's macroglobulinemia
Grade b FL, small lymphocytic lymphoma (SLL), or Waldenstrm's macroglobulinemia (WM) or other lymphoma subtypes except as stated in the inclusion criteria
Waldenstrm macroglobulinemia
Clinicopathological diagnosis of Waldenstroms macroglobulinemia and meeting criteria for treatment using consensus panel criteria from the Second International Workshop on Waldenstroms macroglobulinemia
Waldenstrm macroglobulinemia
Lymphoplasmacytoid lymphoma/Waldenstrm macroglobulinemia (LPL/WM).
Symptomatic disease meeting at least  of the recommendations from the Second International Workshop on Waldenstrm Macroglobulinemia for requiring treatment
Lymphoplasmacytoid lymphoma/Waldenstrm macroglobulinemia (LPL/WM)
Lymphoplasmacytoid lymphoma/Waldenstrm macroglobulinemia (LPL/WM)
Lymphoplasmacytic lymphoma (LPL), with or without associated Waldenstroms Macroglobulinemia (WM)
Waldenstrm macroglobulinemia (WM)
Waldenstrm's macroglobulinemia or IgM myeloma
Grade b FL, small lymphocytic lymphoma (SLL), Waldenstrm macroglobulinemia (WM), or other lymphoma subtypes except as stated in the inclusion criteria
Histologically or cytologically confirmed diagnosis of advanced non-Hodgkin lymphoma (NHL) of any histology (with the exception of participants with Waldenstrm macroglobulinemia [WM] and chronic lymphocytic leukemia [CLL]).
Clinicopathological diagnosis of Waldenstroms macroglobulinemia and meeting criteria for treatment using consensus panel criteria from the Second International Workshop on Waldenstroms macroglobulinemia
Waldenstrm Macroglobulinemia
